Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZN | AMGN | GILD | CELG | BIIB |
| Company | Enzon Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.1110 | 337.03 | 84.39 | 108.01 | 200.57 |
| High | 0.1408 | 338.70 | 84.65 | 108.59 | 204.18 |
| Low | 0.1110 | 334.61 | 83.57 | 107.27 | 200.11 |
| Last | 0.1408 | 337.16 | 84.61 | 108.24 | 203.92 |
| Change | +0.0085 | +4.24 | +0.72 | +0.11 | +6.33 |
| % Change | +6.42% | +1.27% | +0.86% | +0.10% | +3.20% |
| Volume | 10,093 | 588,672 | 3,294,800 | 191,230,496 | 448,211 |
| 20-Day Average Volume | 21,500 | 1,707,250 | 6,413,796 | 16,188,930 | 793,612 |
| Previous Close | 0.1323 | 332.92 | 83.89 | 108.13 | 197.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1417 | 329.62 | 80.10 | 108.17 | 201.66 |
| 20-Day Raw Stochastic | 50.51% | 88.15% | 94.81% | 63.25% | 72.07% |
| 20-Day Relative Strength | 48.61% | 58.17% | 72.81% | 64.69% | 46.87% |
| Weighted Alpha | -35.94 | +27.45 | +19.20 | +46.30 | -20.95 |
| Today's Opinion | 40% Buy | 96% Buy | 88% Buy | 100% Buy | 88% Sell |
| Previous Opinion | 24% Buy | 88% Buy | 88% Buy | 100% Buy | 100% Sell |
| Last Month's Opinion | 72% Buy | 88% Buy | 56% Buy | 100% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.30% since 09/12/24 | +1.99% since 09/12/24 | +1.49% since 09/12/24 | -1.97% since 11/13/19 | +2.43% since 09/12/24 |
| Low | 0.1110 on 09/19/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 192.25 on 09/13/24 |
| High | 0.1408 on 09/19/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 110.53 on 11/14/19 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | -14.67% since 08/19/24 | +2.64% since 08/19/24 | +13.36% since 08/19/24 | +5.14% since 10/18/19 | -1.63% since 08/19/24 |
| Low | 0.1110 on 09/19/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 102.40 on 10/21/19 | 192.25 on 09/13/24 |
| High | 0.1700 on 08/22/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | -6.13% since 06/18/24 | +10.01% since 06/18/24 | +33.64% since 06/18/24 | +13.63% since 08/20/19 | -9.36% since 06/18/24 |
| Low | 0.1110 on 09/19/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 192.25 on 09/13/24 |
| High | 0.1955 on 06/26/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | +134.67% since 03/19/24 | +23.88% since 03/19/24 | +14.96% since 03/19/24 | +14.14% since 05/20/19 | -7.28% since 03/19/24 |
| Low | 0.0600 on 04/01/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 0.2400 on 06/10/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,819 | 178,589,936 | 104,514,608 | 77,035,920 | 28,768,510 |
| Shares Outstanding, K | 74,220 | 536,435 | 1,245,853 | 711,714 | 145,597 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | 1,370,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 30,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 2,464,900,000 |
| Last Quarter Net Income | 280,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | 583,600,000 |
| 60-Month Beta | 0.51 | 0.61 | 0.18 | 1.41 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 08/08/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 5.28 on 08/01/24 |
| Latest Earnings Date | 08/19/24 | 10/29/24 | 11/05/24 | 10/31/19 | 08/01/24 |
| Most Recent Dividend | 0.240 on 09/30/19 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | 09/30/19 | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 13.50 | 17.89 | 17.67 | 10.99 | 12.19 |